Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Hmmmmm which company does this?????
Looking further ahead, peptide-drug conjugates (PDCs) are a viable alternative to antibody-drug conjugates (ADCs), Cochran said. PDCs offer faster clearance of toxic payloads and enhanced tumor penetration due to their small size
We know ava6000 is shrinking tumours
https://www.aacr.org/about-the-aacr/newsroom/news-releases/immune-response-to-investigational-rna-vaccine-for-pancreatic-cancer-continues-to-correlate-with-clinical-benefit/
Conclusions: AVA6000 delivers high concentration of doxorubicin to the TME relative to plasma which results in antitumor activity in tumors with high FAP activity. A q2w dose escalation arm is ongoing.
Not been this excited since lft days!!
In all seriousness patience is going to pay handsomely here.
Might be 6 months might be 2 years but Iβm retiring on this stock Iβm convinced
Surely this is going to be monumental in the coming months
Avacta cannot word such promotions/adverts without being slaughtered by financial fair play rules.
They are literally telling shareholders we have the keys!!
Sit and wait folks
It will be worth it
Https://www.aacr.org/blog/2016/10/24/fda-approves-new-treatment-for-soft-tissue-sarcoma/